The race to create a vaccine: A conversation with Frank D’Amelio
McKinsey
DECEMBER 10, 2021
The CFO of the pharmaceutical company talks about what it took to develop a COVID-19 vaccine.
McKinsey
DECEMBER 10, 2021
The CFO of the pharmaceutical company talks about what it took to develop a COVID-19 vaccine.
Vantage Circle
MAY 10, 2021
All of which will imply how the pharmaceutical industry is likely to conduct its business in the near future. It pressurizes the healthcare system, both in terms of nature and scale of the demand and healthcare costs and drug development. Be it sales and distribution or product discovery and development. Scarcity of Talent.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Crestcom
APRIL 8, 2022
How to Make Strategies Stick with Executive Coach, Liz Kislik. On this week’s episode of The Leadership Habit podcast, Jenn Dewall sat down with Liz Kislik to talk about how to make strategies stick. Enjoy our conversation as Liz and Jenn talk about how to make strategies. Why Don’t Our Strategies Stick? I love that.
Harvard Professional Development
MAY 25, 2022
Taking time away from the day-to-day demands of your job to pursue professional development can be challenging. For many of our participants, the most valuable part of the professional development experience is identifying actionable tips and strategies that they can apply immediately upon the return to the office. Eugene Moore.
Strategy+Business
MAY 11, 2014
Looking toward the future, pharmaceutical companies and other stakeholders will adopt existing technologies and develop new ones, creating a more connected digital healthcare ecosystem.' Doctors and patients are starting to use digital tools to manage healthcare more efficiently.
McKinsey
MAY 8, 2019
Vaccine development has slowed over the past five years, but changes to investment strategies and a shift in focus to more technical and complex vaccines could renew the innovation engine.
McKinsey
MAY 13, 2021
The small number of people with rare diseases raises challenges for the development and launch of all therapies for such conditions, but rare cancers face extra barriers to widespread treatment.
Let's personalize your content